Sherbrooke Park Advisers LLC Atri Cure, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 10,792 shares of ATRC stock, worth $412,470. This represents 0.11% of its overall portfolio holdings.
Number of Shares
10,792Holding current value
$412,470% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ATRC
# of Institutions
229Shares Held
47.1MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$178 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$176 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$147 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$112 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$96.6 Million0.51% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.77B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...